Cancer Research AACR Conference on Molecular Diagnostics - 2008  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kammertoens, T.
Right arrow Articles by Blankenstein, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kammertoens, T.
Right arrow Articles by Blankenstein, T.
[Cancer Research 65, 2560-2564, April 1, 2005]
© 2005 American Association for Cancer Research


Priority Reports

CY15, a Malignant Histiocytic Tumor That Is Phenotypically Similar to Immature Dendritic Cells

Thomas Kammertoens1, Ralf Willebrand1, Bettina Erdmann2, Liangping Li2, Yongping Li4, Boris Engels3, Wolfgang Uckert2,3 and Thomas Blankenstein1,2

1 Institute of Immunology, Charité Campus Benjamin Franklin; 2 Max-Delbrück Center for Molecular Medicine; 3 Institute of Biology, Humbold University Berlin, Berlin, Germany; and 4 Zhongshan Ophthalmic Center Sun Yat-sen University, Guangzhou, China

Requests for reprints: Thomas Kammertoens, Institute of Immunology, Hindenburgdamm 30, 12200 Berlin, Germany. Phone: 49-30-8445-3639; Fax: 49-30-8445-4613; E-mail: tkamm{at}mdc-berlin.de.

The origin and pathogenesis of histiocytic malignancies and the biology of the tumor cells are poorly understood. We have isolated a murine histiocytic tumor cell line (CY15) from a BALB/c IFN{gamma}–/– mouse and characterized it in terms of phenotype and function. The morphology, as judged by electron microscopy, and the surface marker phenotype suggests that CY15 cells are similar to immature dendritic cells (CD11c low, MHC II low, CD11b+, B7.1+, B7.2+, and CD40+). The cells form tumors in BALB/c mice and metastasize to spleen, liver, lung, kidney, and to a lesser extend to lymph nodes and bone marrow, as judged by the growth of green fluorescent protein transfected tumor cells in mice. CY15 cells are capable of actively taking up antigen (FITC-ovalbumin) and can stimulate T lymphocytes in an allogenic mixed lymphocyte reaction but less effectively than their normal counterparts (immature dendritic cells). They respond to interleukin 4 (IL-4) with up-regulation of CD11c. If stimulated with IFN{gamma} the cells up-regulate MHC II, CD40 B7.1, and B7.2. Lipopolysaccharide induces the cells to up-regulate B7.1 and B7.2 and to secrete tumor necrosis factor {alpha} and IL-12. Based on these data, CY15 is a dendritic cell–like tumor cell line and may serve as a transplantable tumor model for histiocytosis in humans.

Key Words: dendritic cell neoplasm • histiocytic malignancy




This article has been cited by other articles:


Home page
J. Exp. Med.Home page
N. N. Iwakoshi, M. Pypaert, and L. H. Glimcher
The transcription factor XBP-1 is essential for the development and survival of dendritic cells
J. Exp. Med., October 1, 2007; 204(10): 2267 - 2275.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.